(Q36484679)

English

The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Ryan M Wolfort

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Benjamin D L Li

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Lester W Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Richard H Turnage

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

David Lilien

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Fred Ampil

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Gary Burton

7

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Quyen D Chu

8

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

World Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1422-1427

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

https://scigraph.springernature.com/pub.10.1007/s00268-005-0207-6

0 references

18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDG-PET and beyond: molecular breast cancer imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical applications of PET in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of positron emission tomography in the follow-up for breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SUV: standard uptake or silly useless value?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00268-005-0207-6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36484679&oldid=1635142061"